ESPrit 3G for Nucleus 22

For Release: September 10, 2003

Cochlear will release the ESPrit 3G behind the ear (BTE) speech processor for its first-generation implant, the Nucleus® 22.

This initiative is an integral part of Cochlear’s commitment to offer continuous improvement in hearing outcomes and quality of life for all Nucleus® recipients.

This upgrade will enable Nucleus 22 recipients to access the proven benefits of the world’s latest BTE technology.

The ESPrit 3G is the world’s latest BTE technology.

Key features include:

– The Whisper Setting, designed to improve perception of quiet sounds in environments such as classrooms or work situations.

– An inbuilt telecoil allows cable-free access to hearing aid-compatible phones, and rooms or theatres with induction loop systems.

– Long battery life enables children and adults to get through the whole day without changing batteries.

– A choice of colour combinations and a lightweight stylish design with no long cables makes hearing hassle free.

– Designed for easy access to wireless FM technology through our partnership with Phonak.

Nucleus is a registered trademark of Cochlear Ltd.
ESPrit is a trademark of Cochlear Limited.
This product is not yet commercially available.